Welcome to our Investor Centre

Please click on the Profiles below to see more details on our other clients:

All of the information contained within this website has been compiled from sources believed to be reliable, but no warranty, expressed or implied, is given that the information is complete or accurate or that it is fit for a particular purpose. All such warranties are expressly disclaimed and excluded. Any opinions, recommendations and forecasts referred to are not those of Walbrook PR Limited but are expressly those of third parties, such as investment analysts and financial journalists. Such opinions, recommendations and forecasts may have been superseded and thus may not necessarily be the current opinions, recommendations and forecasts of the relevant analyst/broker. None of the content of this website should be construed as an offer to buy or sell, or a solicitation of an offer to buy or sell, the securities of any listed Company mentioned or featured herein as it is for information only. Any recommendations referred to by third parties do not necessarily imply the suitability of particular securities for individual situations. The value of securities and the income from them may fluctuate. It should be remembered that past performance is not necessarily a guide to future performance. You are strongly advised to seek guidance from a professional investment adviser before entering into any contract to buy or sell any security featured herein. By reading this disclaimer, and ticking the box below, you confirm that you accept and understand its content, and that you shall not hold Walbrook PR Limited, its directors and staff nor any of its subsidiaries or connected companies liable for any loss that you may sustain should you decide to buy or sell any of the mentioned securities.

Yourgene Health plc

Company Profile

Company website
Pharmaceuticals & Biotechnology (Biotechnology)

Yourgene Health plc (AIM: YGEN) is an international molecular diagnostics group which develops and commercialises genetic products and services. Yourgene Health's first commercialised product is the CE marked IONA® test, a non-invasive prenatal tests (NIPT) for Down's syndrome and other genetic disorders.

Investor Access

27 Sep
Event information

The Company's AGM will be held at 2:00pm (BST) on Tuesday 27 September 2022, and will be held as a hybrid meeting electronically, via the Investor Meet Company platform and physically, at the Company's new offices Skelton House, Lloyd Street North, Manchester Science Park, Manchester M15 6SH.

The company will be hosting an Open Day at its new facilities on Manchester Science Park, Manchester, UK on Tuesday 27 September 2022 from 3pm to 6pm, welcoming shareholders, analysts and other interested stakeholders. 

Management will also provide shareholders with a short presentation after the formal business of the AGM concludes and there will be an opportunity for investors to ask questions. Investors can sign up to Investor Meet Company for free and add to meet Yourgene Health plc by clicking here

Online and at the Company's new offices
Tuesday 27th September 2022 at 2pm and 3pm to 6pm
Financial Calendar
 Event  Date
Year End 31 March
Half  Year End 30 September
Preliminary Results* July
Interim Results* December
AGM* September

* Months based on previous announcements of this kind